Called it ! A must read, page-179

Hi Apparelcorp - of course MrD will have his view - for me the question remains centred over the word “IF” in your succinct summary. What “IF” the treatments do not fulfill the final trial parameters or something is determined that is not yet known. It is still in trial territory notwithstanding the journey so far and the monetary developments on market. We hope for the sake of all patients - those who have endured trials for all treatments that failed and on all different trials now, for all patients currently suffering and those of the future that IMU will succeed. If it does this will be a once in a generation stock. We won’t find anything comparable “IF” it works. But it’s the nature of the market and our interest in the market.